# A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

> **NCT00799058** · PHASE1,PHASE2 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 128 (actual)

## Conditions studied

- HIV-1 Infections

## Interventions

- **DRUG:** dapivirine 4789
- **DRUG:** dapivirine gel 4759
- **DRUG:** Drug placebo

## Key facts

- **NCT ID:** NCT00799058
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-06
- **Primary completion:** 2011-01-08
- **Final completion:** 2011-01-08
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799058, "A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00799058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*